Edition 34 – Mifepristone’s REMS Criteria: Dangerous During COVID-19 and Beyond

Mifepristone’s REMS Criteria: Dangerous During COVID-19 and Beyond By Claudia Flores, Kristyn Brandi, Chloe Phillips Citation Flores C, Brandi K, Phillips C. Mifepristone’s REMS criteria: dangerous during COVID-19 and beyond. HPHR. 2021;34. DOI:10.54111/0001/HH18 Mifepristone’s REMS Criteria: Dangerous During COVID-19 and Beyond At a time when COVID-19 transmission is peaking, millions of women have reduced access […]